Registration - Organization

Novo Nordisk Canada Inc. / Vince Lamanna, President

Registration Information

Organization name: Novo Nordisk Canada Inc.
Senior Officer Name: Vince Lamanna, President
Senior Officer Change History
Initial registration start date: 2020-08-27
Registration status: Active
Projected end date: No date provided
Registration number: 9743-3532

Associated Lobbying Activity Reports

Total number of Lobbying Activity Reports: 4

Lobbying Activity Reports - last 6 months: 1

Version 7 of 7 (2024-11-27 to present)

Registration versions:

Version 7 of 7 (2024-11-27 to present)

Lobbying Information

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Yes

Subject matters added through an Lobbying Activity Report:
Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Advocacy regarding policies/issues of public health as it relates to diabetes/obesity management and prevention.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Children and Families, Education, Government Procurement, Health, Hospitals
Policy and program discussions from a broader innovative manufacturer industry perspective regarding the government's delivery of health care and/or access to appropriate/approved medications.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Finances and Budgets, Health, Hospitals
Policy and program discussions from a broader innovative manufacturer industry perspective regarding the government's delivery of health care and/or access to appropriate/approved medications.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Finances and Budgets, Health, Hospitals
Seeking public listing and reimbursement of Novo Nordisk innovative medicines on BC formularies.	Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	Government Procurement, Health, Hospitals
Subject matters added through an Lobbying Activity Report:
Policy and program discussions from a broader innovative manufacturer industry perspective regarding the government's delivery of health care and/or access to appropriate/approved medications.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Finances and Budgets, Health, Hospitals

BC Ministries/Provincial Entities

Finance
Fraser Health Authority
Health
Innovate BC
Interior Health Authority
Member(s) of the BC Legislative Assembly
Nisga'a Valley Health Authority
Northern Health Authority
Provincial Health Services Authority
University of British Columbia
Vancouver Coastal Health Authority
Vancouver Island Health Authority

Organization Details

Senior Officer Name and Position during the Period of this Registration

Vince Lamanna, President

Organization Contact Information

Novo Nordisk Canada Inc.

Address:
101-2476 Argentia Road
Mississauga, ON L5N 6M1
Canada

Telephone number: 403-461-7345

Description of Activities

Novo Nordisk Canada Inc. is an affiliate of Novo Nordisk A/S, a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: hemophilia, growth disorders and obesity.

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Contributors to the Lobbying Activity

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of the organization that has a direct interest in the outcome of the lobbying activity.

Government Funding in the Last 12 Months

No government funding was requested or received within the preceding 12 months.

Coalition Members Information

Novo Nordisk Canada Inc. is not a coalition member.

Affiliates with a Direct Interest in the Outcome

Novo Nordisk A/S (Parent Company)
- Novo Alle 1
  2880 Bagsvaerd
  Copenhagen 2880
  Denmark
Novo Nordisk North America Operations A/S (Shareholder)
- Novo Alle 1
  2880 Bagsvaerd
  Copenhagen 2880
  Denmark

Other Persons or Organizations with Direct Interests

The activities of Novo Nordisk Canada Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.

Lobbyists Details

Lobbyists Employed by this Organization

Lobbyist

Contributions

Martine Carbonneau
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No